Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) over five years over the United States' insistence on confidential information.
This move became public after a official document from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesperson later explained that the United States was demanding access to biological samples for scientific study and profit while was unwilling to share the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged continued dialogue to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can continue.
Broader Context
This rejection follows a comparable situation in Kenya, where a court blocked a related health funding agreement after concerns were filed about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and accountability.
Based on statements, 16 African countries have to date signed similar health pacts, representing over $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment through American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our population should a future disease outbreak emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining structures already set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This framework is designed to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage further discussions with our US partners on how future co-operation might be arranged in a manner that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that talks need to persist considering a large portion of the country's Aids initiatives relied on foreign aid.
"If technical issues arise, including those relating to information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it added.
The halted deal underscores the continuing challenges between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.